CervoMed Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $1.53 at 10:18 AM on Nov 11, then ran to $2.09 +37% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is CRVO up today? It is at $1.83 (+33.58%), and our scanner flagged it 60 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRVO spikes, and full due diligence on CRVO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRVO 60 times in the last 30 days. Create a free account to track $CRVO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CRVO from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystCervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates, from the latest SEC filing. Read it →Across every filing on file, supply equal to 172.2% of the tradeable float is in play - 130% has already been sold, and 42.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent share offering + active shelf on file — the company raised capital and can raise more
16,801,885 new shares · About $10.0M in size · Priced at $3.14/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Boger Joshua S Director | Bought (open market) | +955K 6.3% of company | added 100% | 1.80M | $3.0M at $3.14 | Jun 11, 26 |
Elder William Robert Officer | Bought (open market) | +3K 0.02% of company | added 25% | 13K | $21K at $8.32 | Nov 18, 25 |
Winton Matthew Officer | Bought (open market) | +2K | added 11% | 15K | $12K at $7.95 | Nov 18, 25 |
Alam John J Officer | Bought (open market) | +11K 0.07% of company | added 0.7% | 1.48M | $91K at $8.46 | Nov 17, 25 |
Alam John J Officer | Bought (open market) | +11K 0.07% of company | added 100% | 13K | $91K at $8.46 | Nov 17, 25 |
Elder William Robert Officer | Bought (open market) | +1K | added 11% | 10K | $8K at $8.45 | Nov 17, 25 |
Gregoire Sylvie Director | Bought (open market) | +11K 0.07% of company | added 0.7% | 1.48M | $91K at $8.46 | Nov 17, 25 |
Gregoire Sylvie Director | Bought (open market) | +11K 0.07% of company | added 100% | 13K | $91K at $8.46 | Nov 17, 25 |
Winton Matthew Officer | Bought (open market) | +4K 0.02% of company | added 35% | 14K | $30K at $8.43 | Nov 17, 25 |
Winton Matthew Officer | Bought (open market) | +10K 0.07% of company | n/a | 10K | $76K at $7.57 | Nov 14, 25 |
Alam John J Officer | Bought (open market) | +2K 0.01% of company | added 0.1% | 1.47M | $13K at $7.55 | Nov 14, 25 |
Alam John J Officer | Bought (open market) | +2K 0.01% of company | n/a | 2K | $13K at $7.57 | Nov 14, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CRVO from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
CRVO last traded at $1.83, up 33.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CRVO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRVO 60 times in the last 30 days.
CRVO (CervoMed Inc. Common Stock) trades on XNAS, with a market cap of about $27M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRVO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRVO discussion
Sign in to ask a question or join the discussion.